Related Experiment Videos
Brachytherapy for refractory coronary artery restenosis
Frank Cummins1, Rakesh Jagetia, Joy Nonnweiler
1Wisconsin Heart and Vascular Clinics, Milwaukee, USA.
The Journal of Invasive Cardiology
|April 2, 2003
Summary
Brachytherapy effectively treated recurrent in-stent restenosis in a patient with a history of multiple left anterior descending (LAD) artery interventions. Angiography at 10 months showed a patent LAD, indicating successful long-term outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Radiation Oncology
Background:
- Recurrent in-stent restenosis (ISR) of the left anterior descending (LAD) coronary artery poses a significant challenge in managing patients with coronary artery disease.
- Multiple percutaneous coronary interventions (PCI) may be required, increasing the risk of further complications and limiting treatment options.
Observation:
- A 76-year-old female presented with recurrent angina due to fifth restenosis of a stented LAD.
- Symptoms were consistent with prior angina and responsive to nitroglycerin.
Findings:
- Following balloon angioplasty for the fifth LAD restenosis, the Novoste Beta-Cath Brachytherapy System was utilized.
- At 10-month follow-up angiography, the LAD remained patent with no evidence of in-stent restenosis.
Implications:
- Intracoronary brachytherapy is a viable treatment option for refractory ISR, particularly in complex cases involving the LAD.
- This approach can achieve long-term patency and symptom relief, potentially reducing the need for repeat interventions.
- Brachytherapy offers a valuable therapeutic strategy for managing challenging cases of coronary artery restenosis.